| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 12/30/2009 | WO2009014887A3 Stabilized immune modulatory rna (simra) compounds |
| 12/30/2009 | EP2138584A1 Foamy viral envelope genes |
| 12/30/2009 | EP2138580A1 Vector for gene therapy |
| 12/30/2009 | EP2136778A2 Growth factor mediated cosmeceuticals and use thereof to enhance skin quality |
| 12/30/2009 | EP2136633A1 Oncolytic vaccinia virus cancer therapy |
| 12/30/2009 | EP1470239B1 Psoriasin expression by breast epithelial cells |
| 12/30/2009 | EP1272663B1 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 12/30/2009 | CN101613688A Von willebrand factor (vWF)-cleaving protease |
| 12/30/2009 | CN101613397A Neisserial antigenic peptides |
| 12/30/2009 | CN101612406A SiRNA aiming at RMP gene and application thereof |
| 12/30/2009 | CN101612405A Preparation and application of HBV former C-C gene vaccine |
| 12/30/2009 | CN100575955C Un-expression of protein as marker of tumor transfer |
| 12/30/2009 | CN100575491C Trans menbrance type and secretory type HIV Gag antigen code gene and AIDS vaccine containing said gene |
| 12/30/2009 | CN100574808C Liver targeted high molecule magnetic resonance image-forming contrast synthesizing method |
| 12/29/2009 | US7638620 Use to enhance apoptosis; antiproliferative agents |
| 12/29/2009 | US7638619 Nucleotide sequences coding hepatocyte specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; immunotherapy; antitumor agents |
| 12/29/2009 | US7638599 Enhance uptake of a pharmaceutically active agent into a cell, into or out of an intracellular compartment, and across a cell layer either directly or from a pharmaceutically active agent loaded particle; drug delivery |
| 12/29/2009 | US7638502 Treatment of EBV and KHSV infection and associated abnormal cellular proliferation |
| 12/29/2009 | US7638498 Substances for preventing and treating autoimmune diseases |
| 12/29/2009 | US7638497 For enhancing apoptosis and treating proliferative disorders; antitumor agents |
| 12/29/2009 | US7638482 Protein kinase C zeta as a drug target for arthritis and other inflammatory diseases |
| 12/29/2009 | US7638480 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
| 12/29/2009 | US7638334 Method for generating engineered cells by homologously recombining segments having increased degeneracy |
| 12/29/2009 | US7638332 Low pressure gas accelerated gene gun |
| 12/29/2009 | US7638331 chimeric gene construct composed of a COX-2 promoter operably linked to at least one apoptosis-inducing gene that can cause selectively induced apoptosis in a population of diseased cells; entire classes of cells can be treated with one transfection |
| 12/29/2009 | US7638327 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with expression of B-cells and immunoglobulins); treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 12/29/2009 | US7638322 vascular endothelial growth factor (VEGF); ischemic heart disease |
| 12/29/2009 | US7638277 Diagnosing ovarian cancer by detecting a TADG-12 protein in biological sample, immunoaffinity to an antibody, bioassay, immunoassay |
| 12/29/2009 | US7638272 administering a polypeptide to the cancer cells of the mammal in vivo for sensitizing the cancer cells to the therapeutic chemotherapy, radiation treatment; gene expressed polypeptide; secreted protein acidic and rich in cystein |
| 12/29/2009 | US7638141 Generating multipotent cells from sstem cells isolated from residual cord blood; tissue engineering and regenerative medicine |
| 12/29/2009 | US7638134 Insertion sites in fowlpox vectors |
| 12/29/2009 | US7638122 Stat3 antagonists and their use as vaccines against cancer |
| 12/29/2009 | US7638120 High transgene expression of a pseudotyped adeno-associated virus type |
| 12/29/2009 | US7638119 Method of diminishing the symptoms of neurodegenerative disease |
| 12/24/2009 | US20090318677 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 12/24/2009 | US20090318535 BETA -TrCP1, BETA -TrCP2 AND RSK1 OR RSK2 INHIBITORS AND METHODS FOR SENSITIZING TARGET CELLS TO APOPTOSIS |
| 12/24/2009 | US20090318534 Methods and compositions for the treatment of skin diseases and disorders |
| 12/24/2009 | US20090318531 Small Interfering RNA Specific For HCV And Therapeutic Agent For Hepatitis C Comprising The Same |
| 12/24/2009 | US20090318357 Molecules Preferentially Associated with Effector T Cells or Regulatory T Cells and Methods of Their Use |
| 12/24/2009 | US20090318352 Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins |
| 12/24/2009 | US20090317907 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs |
| 12/24/2009 | US20090317816 Methods for identifying risk of breast cancer and treatments thereof |
| 12/24/2009 | US20090317410 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 12/24/2009 | US20090317405 Antibody and uses thereof |
| 12/24/2009 | US20090317403 Use of CSF-1 Inhibitors |
| 12/24/2009 | US20090317394 Vascular endothelial growth factor-2 |
| 12/24/2009 | US20090317389 Fusion molecules and methods for treatment of immune diseases |
| 12/24/2009 | US20090317376 Compositions And Methods For Lipo Modeling |
| 12/24/2009 | US20090317368 B7-h1, a novel immunoregulatory molecule |
| 12/23/2009 | WO2009155535A2 Compositions, methods and kits for eliciting an immune response |
| 12/23/2009 | WO2009154790A2 Novel metastasis suppresor genes and uses thereof |
| 12/23/2009 | WO2009154452A1 Parvoviral capsid with incorporated Gly-Ala repeat region |
| 12/23/2009 | WO2009153972A1 Agent for prevention of or protection against hypoxic damage comprising mirna as active ingredient |
| 12/23/2009 | WO2009019612A3 Lentiviral gene transfer vectors and their medicinal applications |
| 12/23/2009 | EP2135948A2 ENA nucleic acid drugs modifying splicing in mRNA precursor |
| 12/23/2009 | EP2135947A1 Antagonists of bacterial sequences |
| 12/23/2009 | EP2135945A1 Method for of transcription-degradation dual regulation for protein by antibiotic |
| 12/23/2009 | EP2135623A1 Method of treatment of a BCL-2 disorder using BCL-2 antisense oligomers |
| 12/23/2009 | EP2135600A1 Targeting agent for cancer cell or cancer-associated fibroblast |
| 12/23/2009 | EP2134375A2 piRNA AND USES RELATED THERETO |
| 12/23/2009 | EP2134365A1 Compositions and methods for inhibiting tumor cell growth |
| 12/23/2009 | EP1687329B1 Optimized expression of hpv 58 l1 in yeast |
| 12/23/2009 | EP1290028B1 A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF |
| 12/23/2009 | EP1274861B1 Compositions and methods for identifying and targeting cancer cells |
| 12/23/2009 | EP1274726B1 Therapeutic compounds and methods for modulating v3, a versican isoform |
| 12/23/2009 | EP0844887B1 Aav transduction of myoblasts |
| 12/23/2009 | CN101610793A Long lasting drug formulations |
| 12/23/2009 | CN101608182A Oncogene, recombinant protein derived therefrom, and uses thereof |
| 12/23/2009 | CN101606948A Application of small interfering RNA in preparing medicament for treating colon cancer |
| 12/23/2009 | CN100572542C Systemic viral/ligand gene delivery system and gene therapy |
| 12/23/2009 | CN100572541C Dual-purpose vaccine vector for foot and mouth disease virus, production method and application of the same |
| 12/23/2009 | CN100571786C Vaccine for preventing and/or treating autoimmune disease |
| 12/23/2009 | CN100571785C Relativity between AnnexinA3 and drug resistance of platinum type chemical curing medication for cancer |
| 12/23/2009 | CA2728739A1 Compositions, methods, and kits for eliciting an immune response |
| 12/22/2009 | US7635770 siRNA targeting protein kinase N-3 (PKN-3) |
| 12/22/2009 | US7635769 Oligoribonucleotide derivatives for specific inhibition of gene expression |
| 12/22/2009 | US7635767 Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same |
| 12/22/2009 | US7635766 Insulin-responsive DNA binding proteins-1 and methods to regulate insulin-responsive genes |
| 12/22/2009 | US7635763 Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use |
| 12/22/2009 | US7635752 Ablated SLAM-Dependent Entry |
| 12/22/2009 | US7635688 Gene expression vectors; intensifier dor sequence determiantion; induce immunology response; viricides |
| 12/22/2009 | US7635677 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 12/22/2009 | US7635673 Gene expression inhibition via contacting with tyrphostin; liposomes; drug screening |
| 12/22/2009 | US7635483 Enzymatically inactive streptococcal C5a peptidase (SCP) conjugated or linked to one or more peptides; effective in immunizing a susceptible mammal against beta-hemolytic Streptococcus |
| 12/22/2009 | US7635475 Diabody-type bispecific antibody |
| 12/22/2009 | US7635468 Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine |
| 12/22/2009 | CA2354024C A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 12/22/2009 | CA2330190C Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells |
| 12/22/2009 | CA2215244C Method for in vitro preconditioning of myoblasts before transplantation |
| 12/19/2009 | CA2633246A1 Identification of therapeutic agents for hiv infection |
| 12/17/2009 | WO2009152480A2 Methods to treat solid tumors |
| 12/17/2009 | WO2009151620A2 Pain treatment using erk2 inhibitors |
| 12/17/2009 | WO2009151503A2 Compositions and methods for the treatment of a neoplasia |
| 12/17/2009 | WO2009151207A1 Mesenchymal stem cells which express human hepatic growth factor, manufacturing method thereof, and use thereof as therapeutic agent for liver diseases |
| 12/17/2009 | WO2009150431A1 Vector |
| 12/17/2009 | WO2009126651A3 Mat ii subunit rnai and therapeutic methods using same |
| 12/17/2009 | US20090312402 Encapsulated nanoparticles for drug delivery |
| 12/17/2009 | US20090312400 Methods for Therapy of Neurodegenerative Disease of the Brain |
| 12/17/2009 | US20090312397 RNAi Modulation Of ApoB And Uses Thereof |
| 12/17/2009 | US20090312263 Gene Differentially Expressed in Breast and Bladder Cancer and Encoded Polypeptides |